Science Corp, a neurotechnology startup, has announced it will begin selling a specialized retina chip in Europe designed to restore partial sight to individuals suffering from age-related blindness. This breakthrough represents a major commercial step for the company, which focuses on advanced medical interfaces.
A Milestone in Neural Engineering
The implant is specifically aimed at patients with forms of age-related macular degeneration, a condition that often leads to severe vision loss. By bypassing damaged photoreceptors and stimulating the remaining neural pathways, the chip allows users to regain a functional level of visual perception.
Future Ambitions
While the retina chip is the company's first major commercial release, Science Corp has broader ambitions in the field of brain-computer interfaces (BCI). The success of this European rollout is seen as a foundational step toward developing more complex brain implants intended to treat a variety of neurological conditions and enhance human cognition.
